Live Quote · NASDAQBCAXHealthcare· Biotechnology

Bicara Therapeutics Inc. Common Stock

$8.44▼ 7.46%($-0.68)
MKT CAP $560.31MNEXT EARNINGS Mar 29, 2027
50%
Bullish
TickerSpark Score
47/100
▌ Weak
87
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCAX research report →

Analyst Price Target
$28.29+235.2% vs. today

Range $8 – $41

Analyst RatingBuy
7 Buy2 Hold1 Sell

Price Chart

-47.84% · this period
$30.40$19.16$7.93Nov 20May 26Nov 20
52-Week Range2% of range
Low
$7.87
Current
$8.44
High
$30.99